Publications by authors named "E Zanon"

Claim this Profile
A
Advantages of FVIII-Extended Half-Life (Turoctocog Alfa Pegol) in the Management of Cardiac Surgery in a Patient with Mild Hemophilia A: A Case Report and Literature Review.
Angela Napolitano, Andrea Venturini, Mauro Ronzoni, Graziella Saggiorato, Paolo Simioni, Ezio Zanon

Hematol Rep· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FVIII half-life products: A real-world experience.
Ezio Zanon, Annamaria Porreca, Angela Napolitano, Chiara Simion, Paolo Simioni

Thromb Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Joint health status in people with moderate hemophilia A: a cross-sectional multicenter study.
Ilenia Lorenza Calcaterra, Federico Picasso, Federica Valeri, Erminia Baldacci, Mariasanta Napolitano, Ezio Zanon

Res Pract Thromb Haemost· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver-related aspects of valoctocogene roxaparvovec gene therapy for hemophilia A: expert guidance for clinical practice.
Vincenzo La Mura, Vincenzo Cardinale, Raimondo De Cristofaro, Adriano De Santis, Giovanni Di Minno, Ezio Zanon

Blood Adv· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Efficacy and Safety of Plasma-Derived Von Willebrand Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy.
Augusto B Federici, Rita Carlotta Santoro, Cristina Santoro, Lisa Pieri, Roberto Mario Santi, Ezio Zanon

Clin Appl Thromb Hemost· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis